NCT00000617View on ClinicalTrials.gov

Azithromycin and Coronary Events Study (ACES)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 1998

Study Completion Date

November 30, 2005

Conditions

Coronary DiseaseHeart DiseasesMyocardial InfarctionCardiovascular Diseases

Interventions

DRUG

azithromycin

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000617 - Azithromycin and Coronary Events Study (ACES) | Biotech Hunter | Biotech Hunter